Cargando…

The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South India

CONTEXT: The guideline recommended dose of intravenous (i.v) recombinant tissue-type plasminogen activator (rt-PA) for acute ischemic stroke is 0.9 mg/kg in the European and American populations. In Asiatic population, some studies have shown that a lower dose of i.v rt-PA is equally efficacious. AI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, Siju V., Thaha, Fazil, Krishnan, S. Vimal, Shajan, Athulya, Balakrishnan, Jayaraj Mymbilly, Palatty, Babu Urumese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341265/ https://www.ncbi.nlm.nih.gov/pubmed/28298840 http://dx.doi.org/10.4103/0972-2327.199911

Ejemplares similares

Factors delaying management of acute stroke: An Indian scenario
por: Abraham, Siju V., et al.
Publicado: (2017)

Door to balloon time in patients presenting with acute ST elevation myocardial infarction and time factors influencing it; an observational study from a tertiary care teaching hospital in India
por: Krishnan S, Vimal, et al.
Publicado: (2021)

Utility of Point-of-Care Lung Ultrasound for Initial Assessment of Acute Respiratory Distress Syndrome Patients in the Emergency Department
por: Sanjan, A., et al.
Publicado: (2019)

Factors Affecting Early Treatment Goals of Sepsis Patients Presenting to the Emergency Department
por: Kassyap, C. K., et al.
Publicado: (2018)

A Comparison between Ultrasound-guided Short-axis Approach and Oblique Axis Approach for Internal Jugular Venous Cannulation in the Emergency Department
por: Sunny, Arin Eliza, et al.
Publicado: (2021)

Chest Compression Fraction and Factors influencing it
por: Mathew, Deo, et al.
Publicado: (2022)

A Comparison of Internal Jugular Vein Cannulation by Ultrasound-Guided and Anatomical Landmark Technique in Resource-Limited Emergency Department Setting
por: Kunhahamed, Meenhas Oravil, et al.
Publicado: (2019)

Utility of Clot Waveform Analysis in Russell's Viper Bite Victims with Hematotoxicity
por: Abraham, Siju V., et al.
Publicado: (2018)

Survival following intentional succinylcholine injection for self-harm
por: Kunhahamed, Meenhas Oravil, et al.
Publicado: (2020)

Reliability of Ultrasonography in Confirming Endotracheal Tube Placement in an Emergency Setting
por: Thomas, Vimal Koshy, et al.
Publicado: (2017)

Assessment of the Preparedness and Planning of Academic Emergency Departments in India During the COVID-19 Pandemic: A Multicentric Survey
por: Gopinathan, Vivek, et al.
Publicado: (2021)

What's New in Critical Illness and Injury Science?: In situ simulation for airway management during COVID-19 in the emergency department, KMC, Manipal
por: Sanjan, A., et al.
Publicado: (2020)

Infection Control Measures, in situ Simulation, and Failure Modes and Effect Analysis to Fine-Tune Change Management during COVID-19
por: Lateef, Fatimah, et al.
Publicado: (2020)

Caval Aortic Index: A Novel Tool for Fluid Assessment in Obstetric Emergencies
por: Menon, Lakshmi Priya, et al.
Publicado: (2020)

Indigenously Developed Ultrasound Phantom Model versus a Commercially Available Training Model: Randomized Double-blinded Study to Assess Its Utility to Teach Ultrasound Guided Vascular Access in a Controlled Setting
por: Abraham, Siju V., et al.
Publicado: (2022)

Adding an “R” in the “DOPE” Mnemonic for Ventilator Troubleshooting
por: Thomas, Vimal Koshy, et al.
Publicado: (2018)

Portable Biosafety Barrier Innovations to Limit Transmissibility of Infectious Diseases during Patient Care in Resource-limited Settings during the COVID-19 Pandemic
por: Balakrishnan, Jayaraj Mymbilly, et al.
Publicado: (2022)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011)

An Analysis of the Efficacy of Different Teaching Modalities in Imparting Adult Cardiopulmonary Resuscitation Skills among First-year Medical Students: A Pilot Study
por: Suseel, Appu, et al.
Publicado: (2019)

From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer
por: Didiasova, Miroslava, et al.
Publicado: (2014)

Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study
por: Zengin, Emine, et al.
Publicado: (2021)

Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction
por: Raczyńska, Dorota, et al.
Publicado: (2015)

Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13
por: Fan, Mengchen, et al.
Publicado: (2016)

Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment
por: Liu, Yonge, et al.
Publicado: (2020)

Long-term stability of recombinant tissue plasminogen activator at -80 C
por: Shaw, George J, et al.
Publicado: (2009)

Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
por: Yang, Hung-Wei, et al.
Publicado: (2012)

Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
por: Bäumer, Wolfgang, et al.
Publicado: (2013)

Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
por: Dybowska, Małgorzata, et al.
Publicado: (2020)

Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage
por: Teekaput, Chutithep, et al.
Publicado: (2022)

Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review
por: Jung, Kee-Taig, et al.
Publicado: (2010)

Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
por: Tseng, Yi-Ju, et al.
Publicado: (2020)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

A Neonatal Thrombosis Patient Treated Successfully with Recombinant Tissue Plasminogen Activator
por: Erdinç, Kemal, et al.
Publicado: (2013)

Stability of Recombinant Tissue Plasminogen Activator at −30 °C Over One Year
por: Alkatheri, Abdulmalik
Publicado: (2012)

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator
por: Ong, Cheung-Ter, et al.
Publicado: (2017)

Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
por: Essig, Fabian, et al.
Publicado: (2021)

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
por: Hong, Keun-Sik, et al.
Publicado: (2009)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k807iich1jc8t8nsdd5m2r1nhc